4. Bibliografía
4. Bibliografía:
1.
Alapetite C, Thirion P, de la Rochefordiere A, Cosset JM, Moustacchi E. Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer. 1999 Sep 24;83(1):83-90.
2.
Barber J., West C., Kiltie A., Roberts S., Scott D. Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia-telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy. Rad Res 153: 570-578; 2000.
3.
Bentzen S. M., Tucker S. L. Individualization of radiotherapy dose prescriptions by means of an in vitro radiosensitivity assay. Radiother. Oncol 46: 216-218; 1998.
4.
Borgmann K, Roper B, El-Awady R, Brackrock S, Bigalke M, Dork T, Alberti W, Dikomey E, Dahm-Daphi J. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol. 2002 Aug;64(2):141-52.
5.
Burnet N. G., Wurm R., Nyman J. and Peacock J. H. Normal tissue radiosensitivity: how important is it? Clin. Oncol. 8:25-34; 1996.
6.
Crompton N., Miralbell R., Rutz H., Ersoy F., Sanal O., Wellmann D., Bieri S., Coucke P., Emery G., Shi Y., Blattmann H., Ozsahin M. Altered apoptotic profiles in irradiated patients with increased toxicity. Int. J. Radiat. Oncol. Biol. Phys. 45(3): 707-714;1999.
7.
Crompton N., Shi Y., Emery G., Wisser L., Blattmann H., Maier A., Li L., Schindler D., Ozsahin H., Ozsahin M. Sources of variation in patient response to radiation treatment. Int. J. Radiat. Oncol. Biol. Phys. 49(2): 547-554;2001.
8.
Darzynkiewicz Z., Bruno., Del Bino G., Gorczyca W., Holtz M., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808; 1992.
9.
Deeley J., Moore J. Nuclear lysate sedimentation measurements of peripheral blood lymphocytes from radiotherapy patients. Int. J. Radiat. Biol.56(6): 963-973; 1989.
10.
Delanian S, Martin M, Bravard A, Luccioni C, Lefaix JL. Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage. Radiother Oncol. 1998 Jun;47(3):255-61.
11.
Dikomey E, Brammer I, Johansen J, Bentzen SM, Overgaard J. Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients. Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):481-90.
12.
Dunst J, Neubauer S, Becker A, Gebhart E. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes. Strahlenther Onkol. 1998 Oct;174(10):510-6.
13.
Geara FB., Peters LJ, Ang KN., Wike JL., Brock WA. Prospective conparison of in vitro normal cell radiosensitivity an normal tissue reaction in radiotherapy patients. Int J Radiat Oncol Biol Phys. 27: 1173-1179; 1993.
14.
Hellman S. Principles of radiation therapy. In: V. T. De Vita, Jr, S. Helman and S. A. Rosenberg (eds). Cancer principles and practice of oncology, pp 227-255, JB Lippincot, Philadelphia (1985).
15.
Herskind c., Bentzen SM., Overgaard J., Overgaard M., Bamberg M., Rodemann HP. Differentiation state of skin fibroblasts cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol. 47 (3): 263-269; 1998.
16.
Horwich A. The future of radiotherapy. Radiother. Oncol 19, 353-356; 1990.
17.
Johansen J, Streffer C, Fuhrmann C, Bentzen SM, Stausbol-Gron B, Overgaard M, Overgaard. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Eur J Cancer. 1998 Feb;34(3):378-83.
18.
Kearsley JH, Fang ZM, Clarke RA. Clinical radiohypersensitivity screening using radiation-induced chromosomal aberrations. Australas Radiol. 1998 Aug;42(3):219-21.
19.
Kiltie AE, Ryan AJ, Swindell R, Barber JB, West CM, Magee B, Hendry JH. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol. 1999 Apr;51(1):55-65.
20.
Lara PC., Russell NS., Smolders IJH., Bartelink H., Begg AC., Coco-Martin JM. Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production. Int J Radiat Biol. 70 (6): 683-692; 1996.
21.
Mackay R. I., Hendry D. H. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiother. Oncol 50 (1): 67-75; 1999.
22.
Nachtrab U, Oppitz U, Flentje M, Stopper H. Radiation-induced micronucleus formation in human skin fibroblasts of patients showing severe and normal tissue damage after radiotherapy. Int J Radiat Biol. 1998 Mar;73(3):279-87.
23.
Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol. 1997 May;43(2):189-95.
24.
Núñez M. I., Guerrero R., López E., Del Moral M., Valenzuela T., Siles E., Villalobos M., Pedraza V., Peacock J., Ruiz de Almodóvar M. DNA damage and prediction of radiation response in lymphocytes and epidermal skin human cells. Int. J. Cancer 8; 1998.
25.
O'Driscoll MC, Scott D, Orton CJ, Kiltie AE, Davidson SE, Hunter RD, West CM. Radiation-induced micronuclei in human fibroblasts in relation to clonogenic radiosensitivity. Br J Cancer. 1998 Dec;78(12):1559-63.
26.
Oppitz U, Baier K, Wulf J, Schakowski R, Flentje M. The in vitro colony assay: a predictor of clinical outcome. Int J Radiat Biol. 2001 Jan;77(1):105-10.
27.
Oppitz U, Denzinger S, Nachtrab U, Flentje M, Stopper H. Radiation-induced comet-formation in human skin fibroblasts from radiotherapy patients with different normal tissue reactions. Strahlenther Onkol. 1999 Jul;175(7):341-6.
28.
Ozsahin M., Ozsahin H., Shi Y., Larsson B., Würgler F., Crompton N. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 lymphocytes. Int. J. Radiat. Oncol. Biol. Phys. 38(2): 429-440;1997.
29.
Peacock J, Ashton A, Bliss J, Bush C, Eady J, Jackson C, Owen R, Regan J, Yarnold J. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol. 2000 May;55(2):173-8.
30.
Pinar B. Tesis Doctoral: Radioterapia radical hiperfraccionada en cáncer de mama localmente avanzado. Predicción de la respuesta tumoral (Ki67) y de la toxicidad radioinducida mediante estudios de linfocitos in vitro (PFGE, apoptosis). Universidad de las Palmas de Gran Canaria, facultad de Ciencias Médicas y de la Salud. Octubre 2002.
31.
Rached E, Schindler R, Beer KT, Vetterli D, Greiner RH. No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy. Radiother Oncol. 1999 Dec;53(3):233-45.
32.
Ramsay J., Birrel G. Normal tissue radiosensitivity in breast cancer patients. Int J Radiol. 31:339-344; 1995.
33.
Rodemann HP., Peterson HP., Schwenke K., Von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microscopy. 5: 1135-1142; 1991.
34.
Rudat V, Dietz A, Conradt C, Weber KJ, Flentje M. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol. 1997 May;43(2):181-8.
35.
Ruiz de Almodovar M J, Guirado D, Isabel Nunez M, Lopez E, Guerrero R, Teresa Valenzuela M, Villalobos M, del Moral R. Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity. Radiother Oncol. 2002 Mar;62(3):327-33.
36.
Russell NS., Lara PC., Grunmels A., Hart AM., Coco-Martin JM., Bartelink H., Begg AC. In vitro differentiation characteristics of human skin fibroblasts: correlation with radiotherapy induced breast fibrosis in patients. In J Radiat Biol. 73 (6): 661-670; 1998.
37.
Sarkaria J., Bush C., Eady J., Peacock J., Steel G., Yarnold J. Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblasts. Radiat. Res. 150(1): 17-22; 1998.
38.
Slonina D, Klimek M, Szpytma T, Gasinska A. Comparison of the radiosensitivity of normal-tissue cells with normal-tissue reactions after radiotherapy. Int J Radiat Biol. 2000 Sep;76(9):1255-64.
39.
Tucker S. L., Turesson I. and Thames H. D. Evidence for individual differences in the radiosensitivity of human skin. Europ. J. Cancer 28 A: 1783-1791; 1992.
40.
Turesson I. The progresión rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother. Oncol 15: 217-226; 1989.
41.
UNSCEAR. Effects on the inmune system. United Nations Scientific Committee on the Effects of Atomic Radiation. Report to the General Assembly, with Snnexes. Annexe B. New York: United NationsA; 1994: 206-214.
42.
West C et al. The intrinsic radiosensitivity of normal and tumor cells. Int. J. Radiat. Biol. 73(4): 409-13; 1998
43.
West C., Davidson S., Elyan S., Swindel R., Roberts S., Orton C., Coyle C., Valentine H., Wilks D., Hunter R., Hendry J. The intrinsic radiosensitivity of normal and tumor cells. Int. J. Radiat. Biol. 73(4): 409-13; 1998.
44.
West CM, Davidson SE, Elyan SA, Valentine H, Roberts SA, Swindell R, Hunter RD. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):10-5.
45.
Withers H. R. Biologic basis of radiation therapy. In: C. A. Pérez and L. W. Brady (eds). Principles and practice of radiation therapy (2nd ed), pp 64-98, JB Lippincot, Philadelphia (1992).
© 2010 BioCancer.com